Ichnos Glenmark Innovation’s Post

Champions Oncology continues to transform research by bringing advancements to oncology research through innovation in our preclinical and clinical studies. To learn more about our remarkable results in preclinical studies, download any of our case studies: https://lnkd.in/g9tUrhi2 #BiTE #CART #DNADamage #multiomics #omics #immunotherapy

Download the white paper “Excellence in Immuno-Oncology Clinical Trials” to learn how to reduce risk and plan for success. This paper offers insights on how to navigate the top operational challenges of IO clinical development, including diversity planning. https://bit.ly/3tyXHvQ #oncology #immunooncology #clinicalresearch #immunotherapy #biotech #genetherapy #CAGT #celltherapy #clinicaltrials

Champions Oncology continues to transform research by bringing advancements to oncology research through innovation in our preclinical and clinical studies. To learn more about our remarkable results in preclinical studies, download any of our case studies: https://lnkd.in/g9tUrhi2 #BiTE #CART #DNADamage #multiomics #omics #immunotherapy

Check out our new case studies that showcase the translational power of Champions Oncology #PDX Models to advance #cancer drug development!

New advancements in epigenetic technologies are transforming clinical application research! Check out this article on how researchers are leveraging DNA methylation and histone modifications for potential cancer classification, anti-obesity drug development, and reversing age-related diseases. Learn about the cutting-edge potential of nanopore sequencing and programmable mRNA-based epigenomic medicines that could pave the way for novel therapeutic approaches, in the future Read more here: https://bit.ly/44NX933

FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies. This single test interrogates over 500 genes to profile a patient's solid tumor, helping to increase the likelihood of identifying an immuno-oncology biomarker or clinically actionable biomarkers that enable targeted therapy options or clinical trial enrollment. Read: https://lnkd.in/d7ZyFW-d #sciencesdelavie #biotechnologie #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #lifesciences #revolution #happy

FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies. This single test interrogates over 500 genes to profile a patient's solid tumor, helping to increase the likelihood of identifying an immuno-oncology biomarker or clinically actionable biomarkers that enable targeted therapy options or clinical trial enrollment. Read: https://lnkd.in/eJ8KFVF5 #sciencesdelavie #biotechnology #biotechnology #innovation #innovations #research #sciences #medicaments #research #drugresearch #laboratories #labs #chemistry #chemistry #biology #biologie #biopharma #rna #rnatherapeutics #arn #revolution #happy

#Epigenetics Market Envisions Notable CAGR Growth in the Years 2023–2032 https://lnkd.in/drVjVNMv Growing prevalence of #cancer and #cardiovascular #diseases is the driving the #epigenetics #market. Increasing adoption of epigenetics drugs as an alternative #treatment to the #conventional cancer #treatment is further fueling the #growth of the epigenetics market. Merck KGaA, Darmstadt, Germany Illumina PacBio abcam Active Motif Bio-Rad Laboratories Promega Corporation PerkinElmer QIAGEN New England Biolabs Zymo Research Corp Diagenode, a Hologic company F. Hoffmann-La Roche Ltd #Epigenetics #biotechnology #business_opportunities #marketanalysis #marketresearch #opportunities #business #future 

#Epigenetics Market Envisions Notable CAGR Growth in the Years 2023–2032 https://lnkd.in/drVjVNMv Epigenetics Epigenetics and Cell Fate Centre Epigenetics International THE EPIGENETICS HEALING CENTER, LLC Cancer Epigenetics Society Max Planck Institute of Immunobiology and Epigenetics Zenith Epigenetics Ltd. Everything Epigenetics Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) Penn Epigenetics Institute Celgene E3:Engaging Epigenetics Experts MarketsandMarkets Epigenetics Congress Lunasin and Nutritional Epigenetics Conscious Epigenetics Novus International, Inc. Zymo Research Corp Tune Therapeutics HudsonAlpha Institute for Biotechnology Constellation Pharmaceuticals, A MorphoSys Company Eurofins Discovery New England Biolabs Dovetail Genomics Active Motif Omega Therapeutics Fountain Life Eurofins DiscoverX MBL International Corporation Chroma Medicine #Epigenetics #biotechnology #business_opportunities #marketanalysis #marketresearch #opportunities #business #future 

Exciting news in the field of drug repurposing! A recent preclinical study has shown that an FDA-approved antidepressant could be a potential treatment for glioblastoma, a currently incurable brain cancer. This innovative approach highlights the power of drug repurposing in offering faster, cost-effective solutions by leveraging existing treatments for new therapeutic uses. As we continue to explore novel applications for approved drugs, we may unlock new hope for patients battling some of the toughest diseases, including PolG disorders and other mitochondrial diseases. Read more about this breakthrough here: https://lnkd.in/d3GKS76w #DrugRepurposing #Glioblastoma #CancerResearch #Biotech #Innovation